for September 2019
JUST RELEASED 🔥🔥🔥
— Antibiotic Steward (@ABsteward) September 3, 2019
Top New ID/Stewardship Journal Articles Rundown: September 2019 https://t.co/ZNHNFNDqmZ📲
A monthly post by @IDstewardship & @ABsteward #IDTwitter #IDMedEd #IDDailyPearl #medtwitter #MedEd #FOAMed
If you find this helpful Please RT/❤️share w others pic.twitter.com/oi9jVWPT3r
NEW🔥🔥 large VA cohort study CID @Vanessa_S91 @kelechevarria @TimbrookTT
— Antibiotic Steward (@ABsteward) September 3, 2019
Pts treated w oral vancomycin were no more likely to develop VRE from clinical or surveillance sources at 3- or 6-months post CDI treatment than metronidazole-treated pts#IDTwitter https://t.co/dnbr2uv5y9 pic.twitter.com/9DmG0gZxKQ
Sooooo happy to see our book 'Antimicrobial Stewardship for #Nursing Practice' coming out in Feb 2020! Thank you to all the authors and collaborators! https://t.co/NhViToFcee
— Enrique Castro 🇪🇸🇬🇧🇨🇺🇵🇪🇪🇺 (@castrocloud) September 26, 2019
I have some big news!
— 🍎🍁🍂 Autumn Yeen 🍂🍁🍎 (@sailorrooscout) September 26, 2019
Today I was notified that I received the position of Senior Scientist (Biologist) at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health in their Molecular Microbiology Lab in Maryland. https://t.co/f6ojsONR4d
NEW🔥🔥 CID by @SIDPharm @jpogue1 @Keith_S_Kaye @SICUPharmD @IDPharmProf @mveveID
— Antibiotic Steward (@ABsteward) September 23, 2019
Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa. #IDTwitter https://t.co/vjDuMOUly9 pic.twitter.com/5FB6GPyTEA
NEW 🔥🔥 RCT in CID
— Antibiotic Steward (@ABsteward) September 27, 2019
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset CDI in Targeted Patients During Systemic Antibiotic Exposure.#IDTwitter #IDuptodate #medtwitter https://t.co/KvWEVvMJdI pic.twitter.com/po3lhZ8LVh
NEW🔥🔥 Review Article @SIDPharm members and @ConanMacDougall
— Antibiotic Steward (@ABsteward) September 16, 2019
Recognizing and Overcoming Resistance to New
Beta-Lactam/Beta-Lactamase Inhibitor Combinations. A must read #IDTwitter #medtwitter https://t.co/vvm4vMraXx pic.twitter.com/xMRWPdpYmX
#antimicrobialstewardship is about social & behavioural change. @BSACandJAC and @ARC_at_Imperial have launched a #free course to help: Antimicrobial Resistance and Social Science - FutureLearn #AMR #FIPcongress #fip2019 @FIPEd @FIP_org @FIP_CPS @FIP_IPShttps://t.co/yvJYrJVcwK
— Philip Howard (@AntibioticLeeds) September 24, 2019
Antimicrobial resistance (AMR) is a serious threat to public health in the WHO/Europe Region. That’s why next week we launch a French-language version of the extremely popular Massive Open Online Course on antibiotic stewardship for clinicians: https://t.co/oOfzTZbH8g pic.twitter.com/6Wm2trfwbd
— WHO/Europe (@WHO_Europe) September 30, 2019
NEW🔥 Meta-analysis in #IJAA
— Antibiotic Steward (@ABsteward) September 15, 2019
CAZ-AVI are comparable with carbapenems in efficacy and safety for the treatment of Enterobacteriaceae infections.
✨CAZ-AVI can be used as carbapenem sparing agent🤔
#IDTwitter https://t.co/axF9rC7l6u pic.twitter.com/mjlCLGmlPH
NEW Review Article 🔥🔥 @PharmacoJournal @SIDPharm members and @IDpharmresearch
— Antibiotic Steward (@ABsteward) September 5, 2019
Parenteral Fosfomycin: A New Ally in the Fight Against Multidrug‐Resistant Bacterial Pathogens. #IDTwitter https://t.co/OLGTaBtUbf pic.twitter.com/gTFa8veG2Y
A NEW🔥 systematic review & meta-analysis in OFID
— Antibiotic Steward (@ABsteward) September 9, 2019
✨No differences in clinical outcomes between carbapenems and non-carba β-lactams in cIAIs.
✨Clinical /micro failure more in Pts treated with imipenem vs alternative β-lactams mono /combination.#IDTwitter https://t.co/WTRoEBTKdQ pic.twitter.com/01yl5bsyMK
NEW🔥🔥 in @CMIJournal @schweitzer_va @MartinLlewelyn@MarcBonten @jesusrbano @EveTacconelli
— Antibiotic Steward (@ABsteward) September 5, 2019
Optimising design of research to evaluate antibiotic stewardship interventions; consensus recommendations of a multinational working group. A must read #IDTwitter https://t.co/3LNgd7AJxB pic.twitter.com/gFLBdHvKul
It's here! 🥳 Our🆓FORUM🤝for all PHARMACY TECHNICIANS interested in antimicrobial stewardship💊has arrived. Sign up✍️today & join our growing online community🌍of professionals @SarahJ_Thomson @AmyJohn89
— BSAC (@BSACandJAC) September 6, 2019
#StopSuperbugs https://t.co/wZ08LM5yEU pic.twitter.com/rfBYVUEkr0
You know cocci + bacilli, but do you know the star-shaped cells of the bacterial genus Stella? A new #MRAJournal article provides 3 Stella genomes to study the genetics of these bacterial stars. Find our author interview + a link to the announcement: https://t.co/0NnskZaRzJ
— ASM (@ASMicrobiology) September 1, 2019
NEW🔥 in AAC @ASMicrobiology @TheIDApprentice @ID_PharmDavid
— Antibiotic Steward (@ABsteward) September 30, 2019
Searching for the Optimal Treatment for Metallo- and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam. #IDTwitter https://t.co/71SbqSFJk9 pic.twitter.com/KrWItftCXH
In a 60-year!! follow-up of a BCG vaccine clinical trial, those who received the BCG vaccine vs placebo had a far lower subsequent lung cancer rate of 18.2 cases vs 45.4 cases per 100 ,000 person-years https://t.co/6Mdh9PBDTZ
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 😷 (@eliowa) September 25, 2019
NEW 🔥 in CID by @SIDPharm Dr. David E. Koren
— Antibiotic Steward (@ABsteward) September 6, 2019
A Call to Action: The Role of Antiretroviral Stewardship in Inpatient Practice, a Joint Policy Paper of @IDSAInfo , @HIVMA, and @aahivmcomm. #IDTwitter https://t.co/7O51ov03yS pic.twitter.com/unPzSXok9t
NEW 🔥 in CID
— Antibiotic Steward (@ABsteward) September 7, 2019
✨Fixed dosing(300 or 500 mg) of liposomal amphotericin B in morbidly obese individuals instead of mg/kg dosing
✨Cap the dose at a maximum weight of 100 kg
How you dose pt >100 kg, adjused body wt, any max dose 🤔 #IDtwitter #IDuptodate https://t.co/o3O3lSaZTl pic.twitter.com/ZAHCM19usV
NEW Multi-center retrospective in OFID 🇪🇸 🇫🇷 UK US @OncIDPharmd @liliabbo
— Antibiotic Steward (@ABsteward) September 29, 2019
Higher MICs (>2 mg/L) Predict 30-day Mortality in patients with LRTI Caused by Multidrug and Extensively Drug Resistant Pseudomonas aeruginosa Treated with Ceftolozane/Tazobactam https://t.co/oZPzuwLAbX pic.twitter.com/uLskH5y4SD
Should antimicrobial doses be fixed? WEIGHT WEIGHT, don't tell me!
— SIDP (@SIDPharm) September 9, 2019
We're excited to announce a new webinar (approved for BCIDP credit) on antibiotic dosing! #IDTwitter #MedEd #SaveABX
Register Now!
Date: Thurs, Sept 26
Time: 12-1:30PM CT
Link: https://t.co/OxQGw2zYI8 pic.twitter.com/18m9jpCw8N
A NEW 🔥🔥 clinical review @AJHPOfficial Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics. #IDTwitter https://t.co/Z9kaVqZ6yk pic.twitter.com/BzMzbFM3bR
— Antibiotic Steward (@ABsteward) September 3, 2019
Vaccination is the most important and powerful tool we have to prevent and eliminate many infectious diseases. Talk to your doctor about #vaccines today. #ivax2protect https://t.co/oplpaz7FEP pic.twitter.com/nDp0reOrGr
— Dr. Robert R. Redfield (@CDCDirector) September 10, 2019
my grandpa has been in the hospital for the past week w/ Acinetobacter baumannii bacteremia.
— Erin McCreary (@ErinMcCreary) September 3, 2019
I keep deleting this, but I think I need to share what I learned about antibiotics and fear, and reinforce the life-saving nature of stewardship [thread] 1/
Bacteria developing new ways to resist antibiotics, doctors warn | Drug resistance | The Guardian https://t.co/HCYL6EunFD
— Laura Piddock (@LauraPiddock) September 11, 2019
Hear from global leaders on #antimicrobialstewardship about how we can tackle #antimicrobialresistance across different contexts & the importance of #patient #public & #policy roles https://t.co/97hyPAXpf9 #Worldpatientsafetyday @monsey_mcleod @castrocloud @RahAhmad pic.twitter.com/EQvUnupX5K
— Esmita Charani (@e_charani) September 17, 2019
New online: Effect of infectious disease consultation on mortality and treatment of patients with #candida bloodstream infections: a retrospective, cohort study https://t.co/6pTD1GlVQO #idtwitter @FungalDoc @cmejiachew
— The Lancet Infectious Diseases (@TheLancetInfDis) September 24, 2019
Antimicrobial Stewardship: Optimization of Antibiotic Practices (Version 2.0) on-line at Stanford and Coursera now has 4035 learners.https://t.co/7p20rRaSkp
— Stan Deresinski (@StanDeresinski) September 2, 2019
Using social media to disseminate research in infection prevention, hospital epidemiology, and #antimicrobialstewardship
— Brad Langford (@BRxAD) September 1, 2019
👏🏼👏🏼 @KellyCawcuttMD @DrJRMarcelin @JulieSilverMDhttps://t.co/1jujnvZg2m via @ICHEJournal
"Vaccine hesitancy" is science illiteracy. I am all for parents caring about their kids, but if you can't or don't understand how infectious diseases or immunology work and your "concern" endangers your child & others then that's not a defensible position. https://t.co/Pul6K33RxI
— Ryan Marino (@RyanMarino) September 15, 2019
The evolution of #AntibioticResistance #AntimicrobialResistance #AMR. Perfect for almost any level of scientific knowledge. @sciencemagazine https://t.co/RrYqVn3iTb. pic.twitter.com/BO7bghNPBY
— Andrew Morris (@ASPphysician) September 19, 2019
Another great new 📄 resource from my favorite journal: CMR! This one on the major problem organism #Pseudomonas 😷
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) September 19, 2019
Impressive number of drugs reviewed here. ➕ Add it to your ID lit library for future reference! #IDtwitter
📲 https://t.co/XgEe3tHYCM via @ASMicrobiology pic.twitter.com/PcZp2LJ3JR
NEW 🔥🔥 from the author @IDSAInfo CDI guidelines& Dr. Srinivasan @ICHEJournal
— Antibiotic Steward (@ABsteward) September 16, 2019
Hospital-level high-risk antibiotic use in relation to hospital associated CDI :Retrospective analysis of 2016–2017 data from US hospitals #IDTwitter https://t.co/vifXKQx4nu pic.twitter.com/2kHpPugzDT
For those believing that nitrites help you distinguish between gram+ and - urinary isolates, there is this recent study of S. aureus bacteræmia from urine, where 1/2 of urines were nitrite+. Useless. doi: 10.1093/cid/ciy1000.https://t.co/AEARVtpskK #removethenitrites pic.twitter.com/10t9jrXqEQ
— Andrew Morris (@ASPphysician) September 16, 2019
#Vaccines help to combat the spread of infectious tropical diseases. Scientists from @BristolUni and @CNRS have used synthetic biology and #Cloud tech to produce a candidate vaccine against the mosquito-borne chikungunya virus: https://t.co/RZhlQAgQi8 #SynBio #Biodesign pic.twitter.com/RXEpoqVhbq
— Oracle (@Oracle) September 26, 2019
Today is #WorldPharmacistsDay #WorldPharmacistDay2019 #WorldPharmacistDay so here is how pharmacists are doing stewardship 🌎🌍🌏
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) September 25, 2019
🇯🇵 https://t.co/ClNiiIdKtO
🇨🇦 https://t.co/KCPLuzUWov
🇨🇷 https://t.co/3WTWz1NHtB#IDtwitter #SaveABX #Pharmacist pic.twitter.com/RdNq4GdcpC
NEW 🔥 by Dr. Nathan Shively @TomWalshMD13 @matthewmof31
— Antibiotic Steward (@ABsteward) September 5, 2019
Impact of a Telehealth-based Antimicrobial Stewardship Program in a Community Hospital Health System. #IDTwitter
Impressive Results https://t.co/vwBs9CFmRD pic.twitter.com/WhvKwdQ0Xv
NEW🔥 in CID @eliowa @MGoto_Iowa @balexander51 @danlivorsi
— Antibiotic Steward (@ABsteward) September 28, 2019
Inpatient Fluoroquinolone Stewardship Improves the Quantity &Quality of Fluoroquinolone-prescribing at Hospital Discharge: A Retrospective Analysis among 122 VA Hospitals. #IDTwitter https://t.co/FIGe4MZFUz pic.twitter.com/cqDOHplzZq
NEW🔥 Quasi-experimental study in Hem Onc Unit
— Antibiotic Steward (@ABsteward) September 18, 2019
An antibiotic cycling-based based strategy for FN effectively ⬇️ carbapenem use, which may have resulted in ⬇️ VRE colonization and infection &⬇️ daptomycin prescribing #IDTwitter #medtwitter https://t.co/NlYescikXX pic.twitter.com/TdJ4X0PuV7
De-adoption of Routine Urine Culture Testing—A Call to Action | @JAMAInternalMed @USPSTF Colleagues, please read, STOP ORDERING UNNECESSARY URINE CULTURES and STOP TREATING ASYMPTOMATIC BACTERIURIA! @IDSAInfo https://t.co/pK6TiIoo8v
— Carlos del Rio (@CarlosdelRio7) September 24, 2019
Prof. Karin Thursky has been recognised by @ResAustralia for her work driving international leadership in antimicrobial stewardship, which has led to a significant improvement in healthcare https://t.co/47JkzfUSem #WorldSepsisDay @TheRMH @UniMelbMDHS @NCAS_Aus @PeterMacCC
— Doherty Institute (@TheDohertyInst) September 13, 2019
The @PHE_uk #AMRCampaign launches today to raise awareness of antimicrobial resistance. Check out our AMR gateway page and our Antimicrobial stewardship Optimise programme for resources to support you during the campaign. Visit: https://t.co/rokGDIzbed and https://t.co/lPLcy7EVqP pic.twitter.com/BqLPb8zdLb
— CPPE (@cppeengland) September 1, 2019
A blood culture growing Staphylococcus aureus should be treated as a true bloodstream infection. Five things to know: https://t.co/RvW5f1ZW2i #sepsis #infectiousdiseases pic.twitter.com/ACJlhpxXp4
— CMAJ (@CMAJ) September 5, 2019
Here's our statement on the new hospital Condition of Participation final rule.
— SHEA (@SHEA_Epi) September 27, 2019
Infectious Diseases Experts Applaud Inclusion of Antibiotic Stewardship in CMS Condition of Participationhttps://t.co/O52xVZ8qTO
Only 52% of adults said they planned to get a flu shot this season, according to a survey by the National Foundation for Infectious Diseases https://t.co/9VRFyX1B3I
— CNN (@CNN) September 26, 2019
NEW 🔥🔥 ASPECT-NP RCT published in @TheLancetInfDis
— Antibiotic Steward (@ABsteward) September 26, 2019
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia. #IDTwitter #medtwitter https://t.co/xhI2IW1Ead pic.twitter.com/wLczfEIMnV
Trying to reduce your #hospital's #meropenem use? Read this in #JACAMR - Tractable targets for meropenem-sparing #antimicrobial #stewardship... https://t.co/YoJtsfY8X7 #AMR #AntimicrobialResistance #antibiotic
— Gavin Barlow (@gavin_barlow) September 18, 2019
Asked our micro lab director why susceptibilities to Amp/Sulbactam were not reported on a Staph isolate and she pointed me to this paper in #CID Thank you @colleenkraftmd for educating us even on a Saturday! #EmoryID https://t.co/AmqTJQJqyF
— Carlos del Rio (@CarlosdelRio7) September 21, 2019
Presenting today to our nursing colleagues @BrighamWomens on the important role of #nursing in antimicrobial stewardship, hoping to gain some new stewards in the fight against #AntimicrobialResistance. Shout out @DHpharmd for his work in the field! https://t.co/upmhwPe6uF pic.twitter.com/fogS32hwcB
— Jeff Pearson (@jeffpears0n) September 24, 2019
Nice work @cynth_ID!! You are a busy 🐝 these days and I love it!!
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) September 19, 2019
📄 New in ICHE via @SHEA_Epi ➡️ Transitions of care matter for #abxstewardship
📲 https://t.co/GobUPJlGdf pic.twitter.com/BO1RF34LaJ
'Containing healthcare-associated infections through antibiotic stewardship' JAC-Antimicrobial Resistance (JAC-AMR), Volume 1, Issue 2, September 2019 #JACAMRNews dlz047, https://t.co/rCSNLHAuSK
— Antibiotic Action (@TheUrgentNeed) September 3, 2019
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.